Both medications are suitable for individuals who: Have a BMI of 30 or higher (obesity)
GLP-1 (glucagon-like peptide-1) receptor agonists work by helping regulate appetite, slow digestion, and support blood sugar balance
Shareable Preview Images Every shared schedule includes an automatically generated preview image showing your drug concentration chart, perfect for sharing in forums, social media, or with healthcare providers
GLP-1 receptor activation suppresses appetite, slows gastric emptying, and promotes insulin secretion in a glucose-dependent manner
Salehi M, et al
Pharmacological determinants in GLP-1RA-Associated cancer risk Differential cancer risk profiles across GLP-1RA subtypes and dosing regimens Existing studies underscore significant differences in the effect of various GLP-1RAs on the risk of specific cancers, such as pancreatic cancer [68, 26, 27]